Cargando…
TIMP3 Overexpression in Macrophages Protects From Insulin Resistance, Adipose Inflammation, and Nonalcoholic Fatty Liver Disease in Mice
The tissue inhibitor of metalloproteinase (TIMP)3, a stromal protein that restrains the activity of proteases and receptors, is reduced in inflammatory metabolic disorders such as type 2 diabetes mellitus (T2DM) and atherosclerosis. We overexpressed Timp3 in mouse macrophages (MacT3) to analyze its...
Autores principales: | Menghini, Rossella, Casagrande, Viviana, Menini, Stefano, Marino, Arianna, Marzano, Valeria, Hribal, Marta L., Gentileschi, Paolo, Lauro, Davide, Schillaci, Orazio, Pugliese, Giuseppe, Sbraccia, Paolo, Urbani, Andrea, Lauro, Renato, Federici, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266402/ https://www.ncbi.nlm.nih.gov/pubmed/22228717 http://dx.doi.org/10.2337/db11-0613 |
Ejemplares similares
-
Decreased IRS2 and TIMP3 Expression in Monocytes From Offspring of Type 2 Diabetic Patients Is Correlated With Insulin Resistance and Increased Intima-Media Thickness
por: Cardellini, Marina, et al.
Publicado: (2011) -
Restoration of renal TIMP3 levels via genetics and pharmacological approach prevents experimental diabetic nephropathy
por: Casagrande, Viviana, et al.
Publicado: (2021) -
TIMP3 Is Reduced in Atherosclerotic Plaques From Subjects With Type 2 Diabetes and Increased by SirT1
por: Cardellini, Marina, et al.
Publicado: (2009) -
Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay
por: Fiorentino, Loredana, et al.
Publicado: (2013) -
TIMP3 involvement and potentiality in the diagnosis, prognosis and treatment of diabetic nephropathy
por: Casagrande, Viviana, et al.
Publicado: (2021)